Efficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-11, Vol.29, p.ix85-ix85 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | ix85 |
|---|---|
| container_issue | |
| container_start_page | ix85 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Heong, V.Y.M. Lim, Y.W. Lee, S.C. Ow, S. Lim, S.E. Ong, P.Y. Low, J. Ng, J. Ilancheran, A. Tong, P. Lim, D. Tan, D. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy436.022 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy436_022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S092375341943250X</els_id><sourcerecordid>32178171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2302-a5a13f1832fd183cdb148f68e3b30abe43172d3f50f7759e25ecd177134a97ea3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EokPhAdig-wBN659knMCqGhVaqYIF7Tq6ca6pUcaObM-UeTmeDQ9pWbLxlaVzvvtzGHsv-LngnbpA74M3F9vxUKv1OZfyBVuJZt1VLa_FS7binVSVblR9wt6k9JNzvu5k95qdKCl0K7RYsd9X1jqD5gDoR8hhooiDm1w-QLAQJpwxugGch8vk0MOM2ZHPCR5dfoBIZhdj-UPYFx36M5ij22I8wEzR5eAJJwgRLE5TmI-AvBsIDEbjfNjiR7h7IPhaoMEX5b13e4rp2H2D3lCEG5-yy7tMZ_Dd-R84h0hAv450KoK37FVBJ3r3VE_Z_eeru811dfvty83m8rYyUnFZYYNCWdEqacfymnEQdWvXLalBcRyoVkLLUdmGW62bjmRDZhRaC1VjpwnVKRML18SQUiTbP-3ZC94fs-iXLPoli75kUTwfFs-8G7Y0_nM8H78IPi0CKpPvHcU-mb9bja4cNvdjcP_B_wFCe6H8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Heong, V.Y.M. ; Lim, Y.W. ; Lee, S.C. ; Ow, S. ; Lim, S.E. ; Ong, P.Y. ; Low, J. ; Ng, J. ; Ilancheran, A. ; Tong, P. ; Lim, D. ; Tan, D.</creator><creatorcontrib>Heong, V.Y.M. ; Lim, Y.W. ; Lee, S.C. ; Ow, S. ; Lim, S.E. ; Ong, P.Y. ; Low, J. ; Ng, J. ; Ilancheran, A. ; Tong, P. ; Lim, D. ; Tan, D.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy436.022</identifier><identifier>PMID: 32178171</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-11, Vol.29, p.ix85-ix85</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32178171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heong, V.Y.M.</creatorcontrib><creatorcontrib>Lim, Y.W.</creatorcontrib><creatorcontrib>Lee, S.C.</creatorcontrib><creatorcontrib>Ow, S.</creatorcontrib><creatorcontrib>Lim, S.E.</creatorcontrib><creatorcontrib>Ong, P.Y.</creatorcontrib><creatorcontrib>Low, J.</creatorcontrib><creatorcontrib>Ng, J.</creatorcontrib><creatorcontrib>Ilancheran, A.</creatorcontrib><creatorcontrib>Tong, P.</creatorcontrib><creatorcontrib>Lim, D.</creatorcontrib><creatorcontrib>Tan, D.</creatorcontrib><title>Efficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EokPhAdig-wBN659knMCqGhVaqYIF7Tq6ca6pUcaObM-UeTmeDQ9pWbLxlaVzvvtzGHsv-LngnbpA74M3F9vxUKv1OZfyBVuJZt1VLa_FS7binVSVblR9wt6k9JNzvu5k95qdKCl0K7RYsd9X1jqD5gDoR8hhooiDm1w-QLAQJpwxugGch8vk0MOM2ZHPCR5dfoBIZhdj-UPYFx36M5ij22I8wEzR5eAJJwgRLE5TmI-AvBsIDEbjfNjiR7h7IPhaoMEX5b13e4rp2H2D3lCEG5-yy7tMZ_Dd-R84h0hAv450KoK37FVBJ3r3VE_Z_eeru811dfvty83m8rYyUnFZYYNCWdEqacfymnEQdWvXLalBcRyoVkLLUdmGW62bjmRDZhRaC1VjpwnVKRML18SQUiTbP-3ZC94fs-iXLPoli75kUTwfFs-8G7Y0_nM8H78IPi0CKpPvHcU-mb9bja4cNvdjcP_B_wFCe6H8</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Heong, V.Y.M.</creator><creator>Lim, Y.W.</creator><creator>Lee, S.C.</creator><creator>Ow, S.</creator><creator>Lim, S.E.</creator><creator>Ong, P.Y.</creator><creator>Low, J.</creator><creator>Ng, J.</creator><creator>Ilancheran, A.</creator><creator>Tong, P.</creator><creator>Lim, D.</creator><creator>Tan, D.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201811</creationdate><title>Efficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience</title><author>Heong, V.Y.M. ; Lim, Y.W. ; Lee, S.C. ; Ow, S. ; Lim, S.E. ; Ong, P.Y. ; Low, J. ; Ng, J. ; Ilancheran, A. ; Tong, P. ; Lim, D. ; Tan, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2302-a5a13f1832fd183cdb148f68e3b30abe43172d3f50f7759e25ecd177134a97ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heong, V.Y.M.</creatorcontrib><creatorcontrib>Lim, Y.W.</creatorcontrib><creatorcontrib>Lee, S.C.</creatorcontrib><creatorcontrib>Ow, S.</creatorcontrib><creatorcontrib>Lim, S.E.</creatorcontrib><creatorcontrib>Ong, P.Y.</creatorcontrib><creatorcontrib>Low, J.</creatorcontrib><creatorcontrib>Ng, J.</creatorcontrib><creatorcontrib>Ilancheran, A.</creatorcontrib><creatorcontrib>Tong, P.</creatorcontrib><creatorcontrib>Lim, D.</creatorcontrib><creatorcontrib>Tan, D.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heong, V.Y.M.</au><au>Lim, Y.W.</au><au>Lee, S.C.</au><au>Ow, S.</au><au>Lim, S.E.</au><au>Ong, P.Y.</au><au>Low, J.</au><au>Ng, J.</au><au>Ilancheran, A.</au><au>Tong, P.</au><au>Lim, D.</au><au>Tan, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-11</date><risdate>2018</risdate><volume>29</volume><spage>ix85</spage><epage>ix85</epage><pages>ix85-ix85</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32178171</pmid><doi>10.1093/annonc/mdy436.022</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-11, Vol.29, p.ix85-ix85 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy436_022 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Efficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A43%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20tolerability%20of%20olaparib%20in%20Asian%20patients%20with%20recurrent%20ovarian,%20primary%20peritoneal%20or%20fallopian%20tube%20carcinoma:%20The%20National%20University%20Cancer%20Institute,%20Singapore%20experience&rft.jtitle=Annals%20of%20oncology&rft.au=Heong,%20V.Y.M.&rft.date=2018-11&rft.volume=29&rft.spage=ix85&rft.epage=ix85&rft.pages=ix85-ix85&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy436.022&rft_dat=%3Cpubmed_cross%3E32178171%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32178171&rft_els_id=S092375341943250X&rfr_iscdi=true |